Eugenia Madar

Eugenia Madar is a seasoned finance professional with extensive experience in financial analysis and business partnering. Currently serving as a Senior Financial Analyst at Melinta Therapeutics since July 2018, Eugenia previously held similar roles at Shire and Wolters Kluwer, where responsibilities included providing financial support to leadership, managing program spend, and overseeing forecasting and budgeting processes. Additional experience includes a position at Motorola Mobility, where analysis of cost and budget management for product development was key. Eugenia holds a Bachelor's degree in Accounting from Roosevelt University.